[Intraoperative magnetic resonance tomography for control of extent of neurosurgical operations]

Radiologe. 1998 Mar;38(3):218-24. doi: 10.1007/s001170050345.
[Article in German]


Purpose: The main aim of our study was to find out whether the combined use of neuronavigation and intraoperative MRI can increase the rate of "complete tumor removal". The second aim was to characterize the different forms of surgically induced enhancement in order to differentiate them from residual tumor.

Materials and methods: Surgery was performed in 18 patients with high-grade glioma. Using a neuronavigation device, the surgeons operated up to the point where they would otherwise have terminated surgery. Intraoperative MRI was then performed to determine whether residual enhancing had been left behind and to update the neuronavigation device. If necessary, feasible surgery was continued. On days 1-3 after surgery early postoperative MRI (1.5 T) was performed. The proportion of patients in whom the enhancing tumor was completely removed was compared with a series of 60 patients with glioblastoma multiforme, who had been operated on using neither neuronavigation nor intraoperative MRI. We also looked for and characterized different types of surgically induced enhancement.

Results: Intraoperative MRI definitely showed residual tumor in 6 of the 18 patients and resulted in ambiguous findings in 3 patients. In 7 patients surgery was continued. Early postoperative MRI showed residual tumor in 3 patients and resulted in uncertain findings in 2 patients. The rate of patients in whom complete removal of enhancing tumor could be achieved was 50% at the time of the intraoperative MR examination and 72% at the time of the early postoperative MR control. The difference in proportion of patients with "complete tumor removal" between the groups who had been operated on using neuronavigation (NN) and intraoperative MRI (ioMRI) and those who had been operated on using only modern neurosurgical techniques except NN and ioMRI was statistically highly significant (Fisher exact test; P = 0.008). Four different types of surgically induced contrast enhancement were observed. These phenomena carry different confounding potentials with residual tumor.

Conclusion: Our preliminary experience with intraoperative MRI in patients with enhancing intraaxial tumors is encouraging. Combined use of neuronavigation and intraoperative MRI was able to increase the proportion of patients in whom complete removal of the enhancing parts of the tumor was achieved. Surgically induced enhancement requires careful analysis of the intraoperative MRI in order not to confuse it with residual tumor.

Publication types

  • English Abstract

MeSH terms

  • Astrocytoma / pathology
  • Astrocytoma / surgery
  • Brain / pathology
  • Brain / surgery
  • Brain Neoplasms / pathology
  • Brain Neoplasms / secondary
  • Brain Neoplasms / surgery*
  • Contrast Media
  • Equipment Design
  • Gadolinium DTPA
  • Glioblastoma / pathology
  • Glioblastoma / surgery
  • Humans
  • Image Enhancement / instrumentation
  • Intraoperative Complications / pathology
  • Intraoperative Complications / surgery*
  • Magnetic Resonance Imaging / instrumentation*
  • Meningeal Neoplasms / pathology
  • Meningeal Neoplasms / surgery
  • Meningioma / pathology
  • Meningioma / surgery
  • Monitoring, Intraoperative / instrumentation*
  • Neoplasm, Residual / pathology
  • Neoplasm, Residual / surgery*
  • Pituitary Neoplasms / pathology
  • Pituitary Neoplasms / surgery
  • Prognosis
  • Radiology, Interventional / instrumentation*
  • Surgical Equipment


  • Contrast Media
  • Gadolinium DTPA